- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04536545
Evaluation of New Semen Collection & Transportation Kit
July 1, 2021 updated by: Turtle Health, Inc.
Evaluation of New Semen Collection & Transportation Kit in Maintaining the Quality of Semen Subjected to Overnight Shipping
Examine the effect of overnight transport conditions on sperm parameters on semen samples collected and mailed to Cleveland Clinic Andrology center.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
66
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Fertile and infertile men in the Cleveland area
Description
Inclusion Criteria:
- Normal healthy men with normozoospermic semen parameters
- Infertile men referred by the infertility specialist (urologist)
Exclusion Criteria:
- Controls with abnormal semen parameters
- Infertile men from other referrals (Gynecologists)
- Severe oligozoospermic (<1 x 106 sperm/mL) infertile men
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sperm concentration
Time Frame: 24 hours
|
Change in sperm concentration from 0 to 24 hours in millions per mL
|
24 hours
|
Sperm motility
Time Frame: 24 hours
|
Change in sperm motility from 0 to 24 hours in %
|
24 hours
|
Sperm forward motility
Time Frame: 24 hours
|
Change in sperm forward motility from 0 to 24 hours in %
|
24 hours
|
Sperm morphology
Time Frame: 24 hours
|
Change in sperm morphology from 0 to 24 hours using Kruger criteria
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sperm concentration
Time Frame: 36 hours
|
Change in sperm concentration from 0 to 36 hours in millions per mL
|
36 hours
|
Sperm motility
Time Frame: 36 hours
|
Change in sperm motility from 0 to 36 hours in %
|
36 hours
|
Sperm forward motility
Time Frame: 36 hours
|
Change in sperm forward motility from 0 to 36 hours in %
|
36 hours
|
Sperm morphology
Time Frame: 36 hours
|
Change in sperm morphology from 0 to 36 hours using Kruger criteria
|
36 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ashok Agarwal, PhD, The Cleveland Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 31, 2020
Primary Completion (Actual)
June 18, 2021
Study Completion (Actual)
June 18, 2021
Study Registration Dates
First Submitted
August 25, 2020
First Submitted That Met QC Criteria
August 28, 2020
First Posted (Actual)
September 2, 2020
Study Record Updates
Last Update Posted (Actual)
July 6, 2021
Last Update Submitted That Met QC Criteria
July 1, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-729
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sperm Parameters in Fertile and Infertile Men
-
The First Hospital of Jilin UniversityRecruitingSexual Dysfunction | Erectile Dysfunction | Premature Ejaculation | Infertile Men | Fertile Men | Wife's MiscarriageChina
-
University Hospital, Clermont-FerrandCompleted
-
Assistance Publique - Hôpitaux de ParisAgence de La BiomédecineCompleted
-
IVI BilbaoAytu BioPharma, Inc.WithdrawnCompare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)Spain
-
Tel-Aviv Sourasky Medical CenterUnknownEndometrial Flora Characterization in Infertile Women
-
Medical University of ViennaVienna University of TechnologyUnknownModulation of Cardiovascular Parameters and Sympathovagal Balance in Healthy SubjectsAustria
-
Quaid-e-Azam UniversityCompletedKisspeptin Action on Insulin in Healthy Normal Men | Kisspeptin Action on Insulin in Obese Diabetic Men
-
BayerCompletedVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenJapan
-
BayerCompletedVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenGermany
-
BayerCompletedVasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenGermany